Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magali Lacroix

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
BMC Cancer|May 6, 2018
The 21-gene Recurrence Score® assay predicts distant recurrence in lymph node-positive, hormone receptor-positive, breast cancer patients treated with adjuvant sequential epirubicin- and docetaxel-based or epirubicin-based chemotherapy (PACS-01 trial)Frédérique Penault-Llorca, Thomas Filleron, Bernard Asselain, et al.
BMC Medical Genomics|April 19, 2015
Fuzzy logic selection as a new reliable tool to identify molecular grade signatures in breast cancer--the INNODIAG studyTatiana Kempowsky-Hamon, Carine Valle, Magali Lacroix-Triki, et al.
Breast Cancer Research : BCR|November 23, 2014
Identification by array comparative genomic hybridization of a new amplicon on chromosome 17q highly recurrent in BRCA1 mutated triple negative breast cancerSébastien Toffoli, Isabelle Bar, Fadi Abdel-Sater, et al.
Nature Communications|February 24, 2019
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent mannerJulien N Bianco, Valérie Bergoglio, Yea-Lih Lin, et al.
Histopathology|July 14, 2024
Development of a deep-learning model tailored for HER2 detection in breast cancer to aid pathologists in interpreting HER2-low casesPierre-Antoine Bannier, Glenn Broeckx, Loïc Herpin, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2019
Improving breast cancer sensitivity to paclitaxel by increasing aneuploidySylvie Rodrigues-Ferreira, Anne Nehlig, Hadia Moindjie, et al.
Clinical Breast Cancer|November 19, 2016
Daily Practice Management of pT1a-b pN0 Breast Carcinoma: A Prospective French ODISSEE Cohort StudyFlorence Dalenc, Frédérique Penault-Llorca, Monique Cohen, et al.
Bulletin Du Cancer|September 20, 2015
[Improving practice in breast pathology: 34-months experience of the regional SENOPATH network and webinars as a tool for diagnosis of difficult lesions of the breast]Marie-Laure Quintyn-Ranty, Karine Gordien, Paul Caveriviere, et al.
The Journal of Pathology|October 26, 2011
Immunophenotypic and genomic characterization of papillary carcinomas of the breastRaphaëlle Duprez, Paul M Wilkerson, Magali Lacroix-Triki, et al.
The Lancet. Oncology|February 11, 2014
Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)Fabrice André, Thomas Bachelot, Frederic Commo, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
BMC Cancer|May 6, 2018
The 21-gene Recurrence Score® assay predicts distant recurrence in lymph node-positive, hormone receptor-positive, breast cancer patients treated with adjuvant sequential epirubicin- and docetaxel-based or epirubicin-based chemotherapy (PACS-01 trial)Frédérique Penault-Llorca, Thomas Filleron, Bernard Asselain, et al.
BMC Medical Genomics|April 19, 2015
Fuzzy logic selection as a new reliable tool to identify molecular grade signatures in breast cancer--the INNODIAG studyTatiana Kempowsky-Hamon, Carine Valle, Magali Lacroix-Triki, et al.
Breast Cancer Research : BCR|November 23, 2014
Identification by array comparative genomic hybridization of a new amplicon on chromosome 17q highly recurrent in BRCA1 mutated triple negative breast cancerSébastien Toffoli, Isabelle Bar, Fadi Abdel-Sater, et al.
Nature Communications|February 24, 2019
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent mannerJulien N Bianco, Valérie Bergoglio, Yea-Lih Lin, et al.
Histopathology|July 14, 2024
Development of a deep-learning model tailored for HER2 detection in breast cancer to aid pathologists in interpreting HER2-low casesPierre-Antoine Bannier, Glenn Broeckx, Loïc Herpin, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 6, 2019
Improving breast cancer sensitivity to paclitaxel by increasing aneuploidySylvie Rodrigues-Ferreira, Anne Nehlig, Hadia Moindjie, et al.
Clinical Breast Cancer|November 19, 2016
Daily Practice Management of pT1a-b pN0 Breast Carcinoma: A Prospective French ODISSEE Cohort StudyFlorence Dalenc, Frédérique Penault-Llorca, Monique Cohen, et al.
Bulletin Du Cancer|September 20, 2015
[Improving practice in breast pathology: 34-months experience of the regional SENOPATH network and webinars as a tool for diagnosis of difficult lesions of the breast]Marie-Laure Quintyn-Ranty, Karine Gordien, Paul Caveriviere, et al.
The Journal of Pathology|October 26, 2011
Immunophenotypic and genomic characterization of papillary carcinomas of the breastRaphaëlle Duprez, Paul M Wilkerson, Magali Lacroix-Triki, et al.
The Lancet. Oncology|February 11, 2014
Comparative genomic hybridisation array and DNA sequencing to direct treatment of metastatic breast cancer: a multicentre, prospective trial (SAFIR01/UNICANCER)Fabrice André, Thomas Bachelot, Frederic Commo, et al.
Pageof 12